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Outer surface protein A (OspA) of the Lyme disease spirochete is primarily produced in the tick vector. OspA,
which is a receptor for attaching spirochetes to the tick gut, is down regulated as the spirochetes leave the tick and
enter the mammalian host. Although OspA is not a major antigen produced in the mammal, the protein appears
to be produced under some conditions and production has been linked to more severe disease. A Lyme disease
vaccine based on recombinant OspA has been approved for human use. However, the vaccine is no longer available,
in part because of fears that OspA causes arthritis in people. To further understand the consequences of OspA
production in the host, we created a Borrelia burgdorferi mutant that was unable to down regulate OspA. C3H/HeN
mice infected with this mutant developed a specific anti-OspA immune response, and the spirochetes were unable
to persist in these mice. In contrast, immunodeficient SCID mice were persistently infected with the mutant. We
conclude that spirochetes producing OspA and B from the flaB promoter in immunocompetent mice stimulate an
immune response that clear the bacteria without any signs of disease development in the mice.
The Lyme disease spirochete Borrelia burgdorferi produces
an array of outer surface lipoproteins (Osps). While some of
the lipoproteins are chromosomally produced, the majority are
produced on extrachromosomal plasmids. As many as 91, or
14.5%, of the genes encoded on plasmids are putative lipopro-
teins (7). Many plasmid-encoded lipoproteins are differentially
expressed in the tick vector or the vertebrate host, indicating
that they function at specific stages in the life cycle of the
spirochete. The function of several lipoproteins has been stud-
ied using genetic and biochemical approaches, but there still
remains much to be learned about these proteins.
OspA and B are two proteins encoded by a single operon on
linear plasmid 54 (lp54). These two surface proteins are pro-
duced in abundance by spirochetes grown in culture. OspA, in
particular, has been the focus of study because the gene en-
coding OspA was among the first B. burgdorferi genes to be
cloned and a recombinant OspA vaccine has been approved
for use in people and animals. However, the vaccine is no
longer available, in part because of fears that the protein or an
immune response against the protein could induce arthritis.
OspA is differentially produced during the natural transmis-
sion cycle of the spirochete. When spirochetes first enter a tick,
OspA is upregulated and the protein is required for tick col-
onization. OspA serves as a ligand for tethering spirochetes to
a receptor in the tick gut (20). When infected ticks feed again,
the spirochetes multiply within the vector, downregulate the
production of OspA and infect the host via the salivary glands
of the tick. Nonspecific natural antibody in a host may be one
signal that down regulates ospA expression (16). Mutants miss-
ing OspA and B are able to infect mice and cause disease (28).
There is conflicting data about the role of OspA in infection
and disease in the murine model of Lyme disease. In rodents
infected by a tick bite, OspA antibodies are rarely, if ever,
detected, indicating lack of expression of this gene, and ospA
transcripts are not found in the dermis at the site of attachment
(15). Mice infected by injection of high doses of cultured or-
ganisms often develop anti-OspA antibodies, most likely be-
cause the inoculum contains many organisms producing the
protein. However, ospA transcripts can only be detected up to
5 days postinfection in rabbits injected with spirochetes (8).
Despite the apparent lack of OspA production in rodents,
signals present at sites of inflammation in the murine model
have been shown to increase OspA production (9). In addition,
lipidated OspA injected into rat joints caused arthritis (5). In
summary, a large body of work supports the view that B.
burgdorferi OspA is primarily a protein that is expressed in the
vector for attachment of spirochetes to the tick gut epithelium.
There are also studies that point to a possible role for OspA in
late stage disease under certain conditions, but the evidence is
largely indirect.
Many studies on B. burgdorferi study gene function by cre-
ating genetic knockouts, whereby a selectable antibiotic
marker is inserted into the gene of interest. Another approach
is to cause the overexpression of a particular gene to see what
phenotype the spirochete exhibits when it is unable to shut off
the gene. In this manner, we have created a spirochete mutant
that constitutively produces OspA and B and tested this mu-
tant in the murine model of Lyme disease to study the role of
OspA in murine infection and disease.
MATERIALS AND METHODS
Mice. Specific-pathogen-free C3H/HeN (C3H) and C3H/SmnCIcr-scid (SCID) mice
(3 to 5 weeks old) were purchased from Frederick Cancer Research Center
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(Frederick, MD) and Harlan Sprague-Dawley, Inc. (Indianapolis, IN), respec-
tively. Mice were maintained in individual isolator cages within an infectious
disease containment room and fed commercial mouse diet and water ad libitum.
Mice were euthanized by carbon dioxide asphyxiation, followed by exsanguina-
tion by cardiocentesis.
Borrelia burgdorferi strains and creation of DNA constructs. Borrelia burgdor-
feri strain B31 MI-A3 was the parental strain used in the experiments. MI-A3,
which was kindly provided by Patricia Rosa (Rocky Mountain Laboratories,
NIAID-NIH, Hamilton, MT), is a clonal isolate of the nonclonal low-passage
infectious strain B31 MI that is missing one circular plasmid, cp9. This strain also
produces a truncated version of OspB that is 18 kDa as opposed to the normal
34-kDa size (10). Two mutants of MI-A3 were created by insertion of pBSV2
shuttle vector modifications into the spirochetes. The shuttle vector pBSV2, also
kindly provided by Patricia Rosa, is derived from B. burgdorferi B31 cp9 and
contains a kanamycin resistance cassette. The first modification of the shuttle
vector was created by inserting the gene BBE22 into the vector to create the
vector pBSV222 as outlined by Strother and de Silva (24). The second modified
shuttle vector was created by insertion of the B31-C1 ospAB gene connected to
the B31-C1 flaB promoter into the pBSV222 shuttle vector to create
pBSV222FA (Fig. 1). The flaB promoter was amplified using primers
pFlaB-F and pFlaB-R, while the ospAB operon was amplified using primers
ospAB-F and ospAB-R (Table 1). The flaB gene is constitutively produced in
spirochetes, so putting its promoter in front of the ospA and ospB genes would
cause constitutive production of these two genes. The pBSV222 shuttle vector
was digested with BamHI and SalI into which the flaB promoter and ospAB
operon construct was ligated. The 3 end of the construct had an XhoI site, which
joined with the SalI site of the vector.
Spirochete transformation and characterization. Spirochetes were electrically
transformed with the two shuttle vector constructs following the methodology of
Samuels (23), and transformants were selected using the methods of Yang et al.
(28). Transformants were tested for the shuttle vector using M13 primers that
spanned the insert region. Once confirmed as containing the shuttle vector, a
plasmid profile was performed on the spirochetes using a set of 29 primers (10).
By this method, two strains of spirochetes were created. The first strain, named
A3-pB22, was created by insertion of the pBSV222 shuttle vector, while the
pBSV222FA shuttle vector was electroporated into spirochetes to create
strain A3-pB22-FA.
The two spirochete strains were tested for overproduction of OspA through
Western blotting. MI-A3, A3-pB22, and A3-pB22-FA were grown in BSK-H
medium at 35°C for 1 week, after which samples were concentrated, boiled, run
on a polyacrylamide gel, and analyzed by Western blotting. Blots were run
against a FlaB monoclonal antibody to check for loading and against an OspB
monoclonal antibody as indirect evidence of OspA production. The entire pro-
tein profile of the three strains was also visualized on a polyacrylamide gel using
SimplyBlue stain (Invitrogen, Carlsbad, CA). To further confirm the activity of
the flaB promoter and ospA gene insert, RNA was harvested from in vitro-grown
spirochetes (RNeasy mini kit; QIAGEN, Valencia, CA) and reverse transcrip-
tion (RT)-PCR was performed on the RNA using QIAGENs Omniscript RNA
transcription kit (Valencia, CA). PCR was performed on the RT-PCR using
primers that amplified a portion of the ospA gene (primers ospA-F/ospA-R) as
well as primers that amplified specifically from the flaB/ospA insert in the A3-
pB22-FA mutant (primers pFlaB-F2/ospA-R) (Table 1).
Mouse infection. Low-passage isolates of B. burgdorferi strains MI-A3, A3-
pB22, and A3-pB22-FA were grown in modified Barbour-Stoenner-Kelly (BSK
II) medium as described previously (3). Sixty C3H mice as well as 60 SCID mice
were randomly divided into three groups of 20 C3H and 20 SCID mice in each.
Mice in one group were infected with 104 spirochetes of the MI-A3, A3-pB22, or
A3-pB22-FA strain at the mid-log phase in 0.1 ml of BSK II by intradermal
FIG. 1. Schematic of the creation of the pBSV222FA shuttle
vector. The shuttle vector consists of three open reading frames from
B. burgdorferi cp9, the E. coli origin of replication, and the two anti-
biotic resistance cassettes. The inserts consisted of the flaB promoter
attached to the ospAB genes as well as the BBE22 gene.
TABLE 1. Primers and probes used in this study
Gene Primer or probe designation Primer or probe sequence (5–3) Source or reference
flaB pFlaB-F GCGGGATCCGTCTGTCGCCTCTTGTGGCTTC This study




ospA ospA-F GCAGCCTTGACGAGAAAAAC This study








ospC OSPC-146F TTACGGATTCTAATGCGGTTTTACT This study
OSPC-235R TACCAATAGCTTTAGCAGCAATTTC This study
OSPC-205p TAGATGACAGCAACGCTTCAACCTCTTTCA This study
flaB-ospAB pFlaB-F2 AACAGGCAAAAGGATTTGCCAAAGTCAGAA This study
FLABOSPAB-F TTTTTAATGCTATTGCTATTTGCGTTT This study
FLABOSPAB-R AAGAACTTTCATTTCACCAGGCA This study
FLABOSPAB-p AAACGCTGTTTTTCTCGTCAAGGCTGCTAA This study
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inoculation at the dorsal thoracic midline of each mouse. At days 4, 15, 30, and
60 postinoculation, necropsy was performed on each of 5 C3H mice and 5 SCID
mice infected with the three strains at each time point. At necropsy, the ear,
heart base, ventricular muscle, and left tibiotarsal joint were individually stored,
snap-frozen, and kept at 70°C until they could be weighed and processed for
DNA and RNA extraction. To confirm the infectious status of each mouse, the
urinary bladder was cultured in modified BSK II medium. The right knee, right
tibiotarsal joint, and the remainder of the heart were formalin fixed, paraffin
embedded, and processed for histological analysis. Slides were coded and exam-
ined in a blinded fashion for prevalence and severity of arthritis and carditis.
Quantitative analysis of B. burgdorferi DNA. DNA was extracted from tissue
samples (ear, heart base, ventricular muscle, and tibiotarsal joint) using DNeasy
kits (QIAGEN, Valencia, CA) according to the manufacturer’s instructions for
tissue and insects. Before DNA extraction, all tissue samples were weighed,
snap-frozen in liquid nitrogen, pulverized, homogenized using a QIAshredder kit
(QIAGEN, Valencia, CA), and then split equally for DNA and RNA extraction.
The B. burgdorferi flaB (flagellin) target gene was expressed per 1 mg of tissue
weight. For real-time PCR amplification, primers and a labeled probe of flaB
gene from published sequences (14) were synthesized to amplify a 107-bp frag-
ment. Real-time PCR was made quantitative by generating a flaB plasmid stan-
dard that was used to create an absolute standard curve as described previously
(13).
Extracted DNA from SCID mice given the A3-pB22-FA strain was also se-
quenced to test for mutations in the inserted plasmid. The entire flaB promoter
and ospAB insert were PCR amplified from DNA that came from the heart tissue
of 1 mouse at 15 days, 2 mice at 30 days, and 1 mouse at 60 days postinfection.
The product of interest was gel purified (QIAGEN, Valencia, CA), ligated into
the pCR2.1 TOPO cloning vector (Invitrogen, Carlsbad, CA), and transformed
into One Shot TOP10 Escherichia coli (Invitrogen, Carlsbad, CA). A clone from
each transformation was verified to contain the plasmid insert and was se-
quenced for the flaB promoter and ospA gene.
Analysis of mRNA. Total RNA from each sample was purified as described
previously (15). Oligonucleotide PCR primers and TaqMan internal probes of
genes that encode flagellin and OspA were based on sequences of B. burgdorferi
strain N40 (14) (Table 1), while sequences from this study were based on strain
B31. Primers OSPC-146F and OSPC-235R (Table 1) were synthesized to amplify
a 90-bp fragment of the ospC gene. The internal oligonucleotide probe OSPC-
205p (Table 1) was labeled at the 5 end with the reporter dye 6-carboxy-
fluorescein and at the 3 end with the quencher dye 6-carboxytetramethyl-
rhodamine. To distinguish between transcriptional activity of ospA that is
constitutively expressed in the mutant from native ospA present normally,
primers and a probe were designed based on the flaB-ospAB open reading
frame that would distinguish between ospA produced from our inserted
construct from natively produced ospA. Primers FLABOSPAB-F and
FLABOSPAB-R were synthesized to amplify a 231-bp fragment, and the
internal oligonucleotide probe FLABOSPAB-p was labeled as the other
probes (Table 1). For absolute quantification of RNA, standard curves were
created with in vitro-transcribed RNA using the RiboProbe in vitro transcrip-
tion system (Promega, Madison, WI).
ELISA. Blood samples were obtained from all C3H mice by tail bleed at 4, 15,
30, and 60 days postinoculation, and serum was separated for serology (enzyme-
linked immunosorbent assay [ELISA]). Microtiter plates (96-well; Nunc Immuno-
Max Maxi-Sorp, Wiesbaden, Germany) were coated with either 1 g/ml of B.
burgdorferi lysate or recombinant OspA in carbonate buffer (pH 9.6) and were
incubated overnight at 4°C. Coated plates were washed with phosphate-buffered
saline-Tween 20 and blocked for 1 h with 1% bovine serum albumin, and then
serial threefold dilutions of serum samples (starting at 1:100) were added to each
well. The plates were incubated overnight at 4°C, washed again, and then incu-
bated for 2 h with alkaline phosphate-conjugated rat anti-mouse immunoglob-
ulin G (heavy and light chains) diluted 1:5,000. Alkaline phosphatase substrate
(Sigma, St. Louis, MO) at 1 mg/ml was added to each well for color development.
The optical density was measured at a test wavelength of 405 nm with an ELISA
reader (Molecular Devices Corporation, Sunnyvale, CA). Each assay included
positive and negative controls for serum. Cut-off points for each dilution were
established by testing the absorbance of normal mouse sera to determine the
means and then adding three standard deviations above the mean.
Arthritis. Rear legs (tibiotarsus and knee) and hearts were processed for
histology by fixation in neutral buffered formalin at pH 7.2. After fixation, bones
were demineralized, and then all tissues were embedded in paraffin. Sections
were cut at 5 m and stained with hematoxylin and eosin. The prevalence of
arthritis in each mouse was determined by examination of one knee and tibio-
tarsus from each mouse and scored as 0, 1, or 2 joints positive. Arthritis severity
in the tibiotarsus was scored on a scale of 0 (negative) to 3 (severe). Sections
through the heart, including the great vessels at the heart base, were examined
for active inflammation, and carditis for each mouse was scored as either present
or absent. All tissue sections were examined blindly.
Statistical comparisons. For the incidence of arthritis, comparisons were
made between C3H and SCID mice infected with the three B. burgdorferi strains
as well as between strains among the C3H and SCID mice. For quantitative PCR
(qPCR) and RT-PCR, evaluations were made between strains among the C3H
and SCID mice. Comparisons were made by using Student’s t test, and calculated
P values of 0.05 were considered significant.
RESULTS
Creation of a B. burgdorferi strain that constitutively pro-
duces OspA and B. A DNA construct containing the ospAB
open reading frame was fused to the flaB promoter to create a
spirochete strain that constitutively produces OspA and B.
This DNA construct was cloned into the B. burgdorferi shuttle
vector pBSV222 that contains a kanamycin resistance cas-
sette and the BBE22 gene from B. burgdorferi lp25 (Fig. 1).
lp25, which encodes genes required for survival of spirochetes
in the tick and the mouse, is a barrier to transformation of
spirochetes, and the plasmid is commonly lost during genetic
manipulation of spirochetes. The gene on lp25 that is princi-
pally required for mouse infection is BBE22 (21). By providing
this gene on the shuttle vector, it is possible to create strains
missing lp25 that are still infectious to mice. Moreover, the
presence of this gene on the shuttle vector serves as a selection
marker in the mouse and prevents plasmid loss.
Two strains of spirochetes were created by introduction of
shuttle vectors. Strain A3-pB22 was created by introduction of
the pBSV222 shuttle vector alone, and strain A3-pB22-FA
was created by introduction of the same shuttle vector with the
addition of the ospAB operon under the control of the flaB
promoter. A plasmid profile of both strains revealed that lp25
was missing from both as expected, while A3-pB22 was addi-
tionally missing lp21 (Table 2). lp21 has been shown previously
not to be necessary for mouse infection (22, 25). Otherwise, all
other plasmids were present. It was not possibly to directly
assess the level of OspA produced from the shuttle vector
because the native copy of OspA is produced at very high levels
in culture, and even at very high dilutions, differences are
difficult to see. However, B. burgdorferi strain MI-A3 has a
premature stop codon in the native ospB gene which leads to
the production of a truncated version of OspB (10). As the
ospAB operon on the shuttle vector construct did not have the
premature stop codon, we could assay for the presence of
full-length OspB as a measure of protein produced off the flaB
promoter on the shuttle vector as indirect evidence of OspA
production. Although Liang et al. (19) showed that OspB
might have regulation independent of OspA in vivo, they and
others have shown that in vitro, both OspA and B are regulated
from the same promoter (6, 17, 19). In fact, full-length OspB
production was seen in the A3-pB22-FA mutant by Western
blots (Fig. 2). The protein profile of the three strains was also
TABLE 2. Spirochete strains used in this study
Strain Introduced DNA Plasmid(s) missing Source or reference
MI-A3 None cp9 10
A3-pB22 pBSV222 cp9, lp25, lp21 This study
A3-pB22-FA pBSV222FA cp9, lp25 This study
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examined, and no obvious differences among levels of proteins
produced among the three strains were obvious (Fig. 2). In
addition, RT-PCR performed on RNA from in vitro-grown
MI-A3 and A3-pB22-FA strains showed that A3-pB22-FA spi-
rochetes produced transcripts from the inserted DNA con-
struct (Fig. 3).
Infection of mice with spirochetes constitutively producing
OspA and B. C3H and SCID mice were injected with the B31
MI-A3, A3-pB22, or A3-pB22-FA spirochete strain and nec-
ropsied 4, 15, 30, and 60 days after infection. By day 15 and
through 60 days postinfection, nearly all mice were infected,
with the exception of the C3H mice given the A3-pB22-FA
strain, which had no infection by organ culture at any time
point tested (Table 3). SCID mice given the A3-pB22-FA
strain, on the other hand, were positive at 15 to 60 days post-
inoculation (Table 3).
A qPCR analysis of spirochete numbers in different tissues
confirmed that A3-pB22-FA was less infectious than MI-A3
and A3-pB22 in C3H mice. Most of the mice did not have
detectable spirochete numbers until 15 days postinoculation
(Fig. 4). In SCID mice, all three strains of spirochetes grew to
similar numbers, although SCID mice generally had higher
bacterial loads than the C3H mice in different tissues and at all
time points (Fig. 4). In C3H mice, B. burgdorferi strains MI-A3
and A3-pB22 were recovered in similar numbers from several
tissues, whereas the A3-pB22-FA strain was detected only
from the heart tissues at 60 days postinoculation and from the
tibiotarsus joints at 15 days postinoculation.
OspA and B expression in mice. We assumed that placement
of the ospAB operon under the regulation of the flaB promoter
would lead to the continuous expression of this operon in
infected animals. Serological studies confirmed that strain A3-
pB22-FA produced more OspA than MI-A3 or A3-pB22.
When sera from C3H mice infected with the B31 MI-A3,
A3-pB22, or A3-pB22-FA spirochete strain were tested by
ELISA using cell lysates from MI-A3 spirochete as an antigen,
all three of the spirochetes induced specific antibody by 15 days
after infection (Fig. 5). No difference in serum reactivity was
seen from days 4 to 30 postinoculation (Fig. 5). A noticeable
rise in reactivity to MI-A3 spirochetes from mice injected with
the MI-A3 strain was seen at 60 days postinoculation. On the
other hand, when sera from mice injected with the three strains
were reacted against recombinant OspA protein, mice injected
with MI-A3 and A3-pB22 spirochetes had little or no reactivity
to OspA. Sera from mice given the A3-pB22-FA strain had
strong reactivity to OspA (Fig. 5). These results confirm that
FIG. 2. Western blot (A) of the spirochete strains showing produc-
tion of full-length OspB for the A3-pB22-FA mutant as well as the
truncated version of OspB (tOspB) produced in all three strains and
total protein (B) showing locations of OspA and full-length OspB.
FIG. 3. PCR of RT-PCR showing ospA transcripts in the MI-A3 and A3-pB22-FA strains (A) and flaB promoter/ospA gene construct
transcripts in the A3-pB22-FA strain (B). (C) PCR of RT-PCRs without reverse transcriptase, showing that the samples contained no DNA
carryover.
TABLE 3. Infection of mice as seen by organ culture at different
time points postinoculation
Strain Mouse type
No. of mice positive/total no. of
mice tested on day:
4 15 30 60
MI-A3 C3H 0/5 5/5 4/5 5/5
SCID 1/5 5/5 5/5 5/5
A3-pB22 C3H 0/5 4/5 4/5 4/5
SCID 0/5 5/5 5/5 5/5
A3-pB22-FA C3H 0/5 0/5 0/5 0/5
SCID 0/5 5/5 5/5 5/5
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FIG. 4. Estimation of spirochete numbers by qPCR in different tissues of C3H and SCID mice 4, 15, 30, and 60 days postinoculation. Cycle
threshold (CT)values of 40 were considered negative (no amplification), and CT values  40 were considered positive. The threshold of detection
was estimated to be 10 spirochetes (14). *, mean significantly different than that of the MI-A3 strain (P  0.05).
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strain A3-pB22-FA produced OspA in C3H mice unlike the
control strains.
We also used RT-PCR to monitor the expression of ospA,
ospC, and flaB in mice at 4, 15, 30 and 60 days postinoculation.
Transcript levels of the three genes were the same or higher in
SCID mice than in C3H mice (Fig. 6). Transcript levels of the
ospC and flaB genes from the A3-pB22-FA strain were com-
parable to the levels produced by the control strains in SCID
mice (Fig. 6). Surprisingly, the A3-pB22-FA strain produced
low levels of ospA transcript in SCID mice that were similar to
the low levels observed for the control Borrelia strains (Fig. 6).
Disease severity in mice infected with spirochetes constitu-
tively producing OspA and B. Although OspA is primarily
produced in the vector, the protein is occasionally produced in
the vertebrate host, and some investigators have proposed that
OspA production is linked to more severe disease. To deter-
mine if OspAB production in the context of a Borrelia infection
was associated with more severe disease, mice infected with
A3-pB22-FA and the control strains were examined for arthri-
tis and carditis at days 15, 30, and 60 after infection. In most
cases, the arthritis and carditis scores were higher for SCID
mice than in C3H mice, as seen by others (4) (Table 4). Of
interest is the lack of carditis in C3H mice for the two mutant
strains compared to the wild type MI-A3 strain, although all
three strains produced carditis in SCID mice. The lack of
carditis for the two mutants, which were both missing lp25,
suggests a role for lp25 in the causation of carditis in C3H
mice. However, the B. burgdorferi strain constitutively produc-
ing OspAB (A3-pB22-FA) did not produce more severe dis-
ease compared to the control strains MI-A3 and A3-pB22 in
SCID mice or C3H mice (Table 4) (P  0.5).
Sequence of A3-pB22-FA mutants from SCID mice. DNA
from 4 SCID mice infected with the A3-pB22-FA strain from
15, 30, and 60 days postinfection was sequenced to test for
possible mutations in the plasmid that might lead to impair-
ment of OspA production. Two of the samples from mice
infected for 15 and 30 days showed no deviations at all from
the known sequence. The other two samples had 2 and 3 single
base pair substitutions, respectively, located in the flaB pro-
moter and ospA gene (Fig. 7).
DISCUSSION
OspA is a Borrelia protein that is primarily produced in the
tick. OspA is down regulated as the spirochetes move from the
tick to a host during a blood meal. In the needle inoculation
model of murine Lyme disease, spirochetes injected into ro-
dents do express ospA for up to 5 days before down regulation
occurs (8). Mutants missing the ospAB operon are infectious to
mice but not to ticks, which further supports a role for these
proteins in the vector and not the host (28). Although OspA is
not a dominant antigen produced by spirochetes in the mam-
malian host, production has been detected under some condi-
tions. In people with Lyme disease, OspA is produced in small
amounts or not at all during the early stages of infection (1, 11,
18, 26). Most people with Lyme disease develop a single or
multiple erythema migrans skin lesions at early stages of in-
fection, biopsies from these sites have shown no ospA mRNA
(11), and sera from patients with erythema migrans have had
little or no reactivity to OspA proteins (18, 26). However, with
the onset of Lyme arthritis 5 months to 7 years after the initial
infection, an antibody response to OspA occurs in some people
in which levels of anti-OspA antibody correlate with severity of
arthritis (1). The possibility that OspA acts as an autoantigen
with similarities to proteins produced in human neural tissue as
well as to a peptide from human leukocyte function-associated
antigen 1 has been proposed (2, 12). In fact, the gene encoding
OspA was among the first B. burgdorferi genes to be cloned,
and a recombinant OspA vaccine was approved for use in
people and animals. However, the vaccine is no longer avail-
able, in part because of fears that the protein or an immune
response against the protein could induce arthritis.
Our results also support the view that the OspAB operon is
not of importance in the murine model of Lyme disease, as
very low levels of ospA transcript and no OspA antibody were
detected in C3H mice infected with the control strains MI-A3
and A3-pB22. C3H mice infected with Borrelia strain A3-pB22-
FA, however, did develop an anti-OspA response. This obser-
vation confirms that the flaB-ospAB construct was expressed to
higher levels in C3H mice than the native ospA which is down
regulated in mice. Spirochetes producing OspA from the flaB
promoter were almost totally cleared from C3H mice, most
likely because of the immune response against OspA.
The conclusion that OspA antibodies in C3H mice cleared
infection was also supported by the fact that strain A3-
pB22-FA was able to persist in SCID mice that cannot mount
a specific immune response. Surprisingly, the overall ospA
transcript level in SCID mice was low even in mice infected
with strain A3-pB22-FA, where ospA is controlled by the con-
stitutive flaB promoter. One possible explanation for this result
is that posttranscriptional mechanisms regulate ospAB mes-
FIG. 5. ELISA results for serum from mice injected with three
strains of spirochetes reacted against MI-A3 spirochetes (A) and OspA
protein (B).
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FIG. 6. RT-PCR of three different strains of spirochetes in C3H and SCID mice at 4, 15, 30, and 60 days postinoculation, where “ospA” represents
native ospA transcripts and “flaB-ospA” represents ospA transcripts produced from the inserted plasmid vector in the A3-pB22-FA mutant. Results for
both ospA transcripts have been scaled differently to show small differences. *, mean significantly different than that of the MI-A3 strain (P  0.05).
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sage levels in the host. Alternatively, it is possible that OspA-
producing spirochetes are under strong negative selection even
in immunodeficient mice. In fact, when the flaB-ospAB con-
struct was sequenced from four mice, two of the mice had point
mutations in the flaB promoter region. However, it is not
known whether the specific point mutations observed had an
affect on ospA transcription. Further studies are needed to
understand why the A3-pB22-FA spirochete mutant produced
low levels of ospA in SCID mice.
Although C3H mice given the A3-pB22-FA strain of spiro-
chetes were not positive by organ culture at all time points
tested, some organs were positive for infection by qPCR and by
RT-PCR. These results suggest that, despite the fact that the
vast majority of mutant spirochetes were cleared from the
mice, some spirochetes were able to persist. These spirochetes
were possibly hidden in immune-privileged areas of the heart
and joints or they were escape mutants, as seen in Xu et al. (27)
for similarly constructed OspC-overproducing spirochetes in
immunocompetent mice.
Some people with Lyme disease develop arthritis that does
not resolve even after successful treatment of the bacterial
infection. Although the exact etiology of treatment-resistant
Lyme arthritis is not known, some investigators believe that an
OspA-induced autoimmune reaction is responsible for this
condition (1, 2, 12, 18). An arthritic reaction to OspA has also
been shown in rats (5), suggesting that constitutive OspA pro-
duction might lead to higher levels of arthritis. A study by
Yang et al. (28) showed that an OspAB-negative mutant ac-
tually caused a more pronounced arthritis than the wild-type
strain, suggesting that OspA is not linked to arthritis in the
murine model of Lyme disease. Strain A3-pB22-FA constitu-
tively producing OspA did not cause any symptoms of acute or
lingering disease in C3H mice. Instead the strain stimulated a
robust OspA antibody response in mice that lead to the clear-
ance of infection.
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